Ralph Lauren Form 144: Insider sale and PSU vesting

Ralph Lauren Corp. filed a Form 144 reporting proposed resale transactions in common stock and recent insider activity.

Rhea-AI Filing Summary

Ralph Lauren Corp. filed a Form 144 reporting proposed resale transactions in common stock and recent insider activity. The filing notes a vesting of 1,120 performance share units on 06/03/2024 granted under the issuer equity compensation plan and shows 1,882 shares sold by Halide Alagoz on 12/02/2025.

Insights

Securities Compliance Counsel

Form 144 documents a claimed resale and prior insider sale activity under Rule 144.

The filing lists a vesting of 1,120 performance share units dated 06/03/2024 and an insider sale of 1,882 shares by Halide Alagoz on 12/02/2025.

These entries align with routine Rule 144 notices; cash‑flow treatment and any broker details are limited to the excerpt, so subsequent filings would show completion and settlement details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Ralph Lauren's (RL) Form 144 disclose?

The Form 144 reports a resale notice and recent insider activity. It records a vesting of 1,120 PSUs on 06/03/2024 and a reported sale of 1,882 shares by Halide Alagoz on 12/02/2025.

Who reported share activity in the RL Form 144?

The filing shows transactions attributed to Halide Alagoz. The excerpt records a sale of 1,882 shares executed on 12/02/2025 and lists broker information linked to Merrill Lynch.

Does the Form 144 show equity awards for Ralph Lauren (RL)?

Yes. The excerpt documents the vesting of 1,120 performance share units on 06/03/2024, noted as granted under the issuer's equity compensation plan.

What dates are important in the RL Form 144 excerpt?

Key dates in the excerpt include the PSU vesting on 06/03/2024 and the insider sale on 12/02/2025. The filing header references 03/04/2026 consistent with the Form 144 submission timeline.

How many shares were sold by insiders in the past three months per the filing?

The excerpt shows an insider sale of 1,882 shares by Halide Alagoz dated 12/02/2025, with an associated value figure listed in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 05:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001940924
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RALPH LAUREN CORP
SEC File Number	001-13057
Address of Issuer	650 MADISON AVENUE NEW YORK NEW YORK 10022
Phone	2123187000
Name of Person for Whose Account the Securities are To Be Sold	Alagoz Halide
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	1120	405440.00	38655137	03/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/03/2024	Vesting of performance share unit award	RALPH LAUREN CORP			1120	06/03/2024	Granted as part of the issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Halide Alagoz 650 MADISON AVENUE New York NY 10022	Common Stock	12/02/2025	1882	688812.00

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Halide Alagoz
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)